DNA Microarrays
Statistical Software for Data Analysis and Clinical Trials
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 5, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Nicole de Leeuw1, Trijnie Dijkhuizen, Jayne Y Hehir-Kwa
1Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
This article reviews how to use public online databases to accurately interpret complex genetic test results from microarray platforms. It provides a guide for clinicians to select appropriate resources for identifying the clinical significance of genetic variations.
Area of Science:
Background:
No prior work has fully resolved the challenges clinicians face when interpreting complex genetic array data. While detecting copy-number variants has become efficient, determining their clinical significance remains a significant hurdle for practitioners. Rapid growth in genomic knowledge creates a landscape where existing diagnostic workflows often struggle to keep pace. That uncertainty drove the need for a structured approach to utilizing external information. Prior research has shown that single-nucleotide polymorphism probes offer detailed genotype information that requires specialized expertise to analyze correctly. Many laboratories possess internal datasets, yet these often lack the breadth of global population information. This gap motivated the current synthesis of available digital tools for diagnostic settings. Clinicians require clear guidance to navigate the vast array of public resources currently accessible for patient care.
Purpose Of The Study:
The aim of this study is to provide a comprehensive summary of internet-based resources for the diagnostic interpretation of genetic array data. This work addresses the difficulty clinicians face when analyzing complex copy-number variants in a clinical setting. The authors seek to clarify which public databases are most appropriate for professional use. This motivation stems from the rapid expansion of genomic knowledge and the increasing resolution of modern array platforms. The study intends to bridge the gap between raw data generation and meaningful clinical reporting. By evaluating various tools, the researchers provide a roadmap for navigating the current landscape of genomic information. They address the need for a standardized strategy that incorporates both genotype and phenotype data. Ultimately, the project seeks to improve the reliability of diagnostic outcomes for patients undergoing genetic testing.
Main Methods:
The review approach involves a systematic evaluation of existing digital tools used for clinical genetic analysis. Researchers examined the characteristics of commonly accessed internet resources to determine their diagnostic suitability. They categorized databases based on the type of information provided, such as genotype or phenotype associations. The study design focuses on synthesizing best practices for interpreting comparative intensity and hybridization signals. Investigators assessed how these platforms support the identification of genetic variations in a clinical context. This analysis excludes proprietary software, focusing instead on publicly available repositories. The team established criteria for selecting resources that are appropriate for professional diagnostic environments. They mapped out a workflow that integrates these diverse sources into a cohesive interpretation strategy.
Main Results:
Key findings from the literature indicate that the interpretation of array data is highly dependent on the quality of external reference information. The authors report that while commercial platforms have improved, the complexity of data requires expert oversight for accurate clinical reporting. They identify that integrating multiple public databases significantly enhances the detection of relevant genetic variations. The review demonstrates that genotype-based array data provides more depth than traditional comparative hybridization methods alone. Findings suggest that fit-for-purpose resources vary depending on whether the clinician is analyzing copy-number variants or single-nucleotide polymorphisms. The literature shows that national registries and global databases offer complementary insights for diagnostic validation. Results emphasize that no single resource is sufficient for all clinical scenarios encountered in modern practice. The authors conclude that a structured, multi-source approach is the most effective way to handle daunting diagnostic data.
Conclusions:
The authors suggest that a systematic approach is necessary for effective diagnostic interpretation of genetic array data. They propose that clinicians prioritize resources based on their specific utility for genotype and phenotype correlation. Synthesis of these tools allows for more reliable assessment of copy-number variants in clinical practice. The review highlights that no single database serves all diagnostic needs across different patient populations. Implications for practice include the necessity of integrating multiple public registries to validate findings from local laboratory data. Researchers emphasize that the quality of interpretation depends on the careful selection of fit-for-purpose internet resources. This work provides a framework to help practitioners manage the increasing complexity of genomic information. The authors conclude that standardized strategies improve the accuracy of diagnostic reporting for patients.
The researchers propose a strategy involving the integration of public genotype and phenotype databases to validate findings. This method helps distinguish between benign variations and pathogenic copy-number variants by comparing patient data against established global population registries.
The authors highlight the utility of single-nucleotide polymorphism probes, which provide detailed genotype information. These tools are contrasted with standard comparative hybridization techniques, which primarily focus on intensity differences rather than specific allelic variations.
A diagnostic setting requires resources that are fit-for-purpose, meaning they must be validated for clinical use. The authors note that while national registries offer specific regional data, public internet databases provide the broader context necessary for rare variant assessment.
Public databases serve as the primary repository for genotype and phenotype information. These resources act as a reference point, allowing laboratories to compare their internal findings against a larger, curated set of known human genetic variations.
The authors evaluate the effectiveness of various platforms by measuring their ability to provide clear, actionable insights. They compare the utility of commercial software packages against open-source internet resources to determine which offers superior diagnostic support.
The researchers propose that standardized interpretation strategies are required to manage the growing complexity of genomic data. They claim that relying on a single source is insufficient for modern diagnostic requirements in clinical genetics.